Federal award
SIEMENS HEALTHCARE DIAGNOSTICS INC.
HT940824C0005
Contract
Obligated and Ceiling
- Obligated (net)
- $1,744,033.22
- Ceiling (potential value, not spending)
- $1,653,183.76
- Current value
- $1,598,053.65
- Gross positive obligations
- $1,744,033.22
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- SIEMENS HEALTHCARE DIAGNOSTICS INC. · GC14SNHB3JN1
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- ALTAIR ENGINEERING INC. · XEAUKVYXD3W1
- Awarding agency
- Department of War · sub-agency 97DH · office HT9408
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- HT940824C0005
- Award type code
- D
- Actions
- 7 · Dec 29, 2023 to May 29, 2026
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History7
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| May 29, 2026 | FY2026 | P00006 | G | $110,260.21 | — |
| Mar 10, 2026 | FY2026 | P00005 | G | $110,260.21 | — |
| Dec 11, 2025 | FY2026 | P00004 | C | $365,780.62 | — |
| Sep 30, 2025 | FY2025 | P00003 | B | $0.00 | — |
| Oct 17, 2024 | FY2025 | P00002 | C | $661,561.25 | — |
| Sep 27, 2024 | FY2024 | P00001 | G | $0.00 | — |
| Dec 29, 2023 | FY2024 | 0 | — | $496,170.93 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.